Evidence map›Paper›PMID 26012576›Full record

ArticleJournal of cellular biochemistry2015

Platelet-Rich Plasma Increases Growth and Motility of Adipose Tissue-Derived Mesenchymal Stem Cells and Controls Adipocyte Secretory Function.

Vittoria D'Esposito, Federica Passaretti, Giuseppe Perruolo, Maria Rosaria Ambrosio, Rossella Valentino, Francesco Oriente, Gregory A Raciti, Cecilia Nigro, Claudia Miele, Gilberto Sammartino and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Vittoria D'EspositoDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Federica PassarettiDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Giuseppe PerruoloInstitute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Naples, Italy.
Maria Rosaria AmbrosioDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Rossella ValentinoInstitute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Naples, Italy.
Francesco OrienteDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Gregory A RacitiInstitute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Naples, Italy.
Cecilia NigroInstitute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Naples, Italy.
Claudia MieleInstitute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Naples, Italy.
Gilberto SammartinoDepartment of Neurosciences, Reproductive and Odonto-stomatological Sciences, Federico II University of Naples, Naples, Italy.
Francesco BeguinotDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Pietro FormisanoDepartment of Translational Medicine, Federico II, University of Naples, Naples, Italy.
Institute for Experimental Endocrinology and Oncology · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipose tissue-derived mesenchymal stem cells (Ad-MSC) and platelet derivatives have been used alone or in combination to achieve regeneration of injured tissues. We have tested the effect of platelet-rich plasma (PRP) on Ad-MSC and adipocyte function. PRP increased Ad-MSC viability, proliferation rate and G1-S cell cycle progression, by at least 7-, 2-, and 2.2-fold, respectively, and reduced caspase 3 cleavage. Higher PRP concentrations or PRPs derived from individuals with higher platelet counts were more effective in increasing Ad-MSC growth. PRP also accelerated cell migration by at least 1.5-fold. However, PRP did not significantly affect mature adipocyte viability, differentiation and expression levels of PPAR-γ and AP-2 mRNAs, while it increased leptin production by 3.5-fold. Interestingly, PRP treatment of mature adipocytes also enhanced the release of Interleukin (IL)-6, IL-8, IL-10, Interferon-γ, and Vascular Endothelial Growth Factor. Thus, data are consistent with a stimulatory effect of platelet derivatives on Ad-MSC growth and motility. Moreover, PRP did not reduce mature adipocyte survival and increased the release of pro-angiogenic factors, which may facilitate tissue regeneration processes.

Indexed as

Platelet-Rich PlasmaRegenerationAdipocytesAdipose TissueCell CycleCell DifferentiationCell ProliferationCell SurvivalGene Expression Regulation, DevelopmentalHumansInterleukinsMesenchymal Stem CellsPPAR gammaInterleukinsPPAR gammaADIPOSE TISSUECYTOKINESGROWTH FACTORSTISSUE REGENERATION

Identifiers

PMID26012576
PMCPMC5042100
OpenAlexW2127014553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.